Combined effect of probucol and insulin on cataracts of diabetic rats fed a high cholesterol diet

European Journal of Pharmacology

Volumn 513, Issue 1-2, 2005, Pages 159-168

  Yoshida, Masumi ^a   Kimura, Hitoshi ^a   Kyuki, Kouhei ^a   Ito, Mikio ^b  

^a Nihon Bioresearch Inc   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Cataract; Diabetes; Hyperglycemia; Hyperlipidemia; Lipid peroxide

Indexed keywords

ANTILIPEMIC AGENT; INSULIN; LIPID PEROXIDE; NPHISZILIN; PROBUCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CATARACT; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG EFFECT; FEEDING; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; INCIDENCE; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CATARACT; CHOLESTEROL; CHOLESTEROL, DIETARY; DIABETES MELLITUS, EXPERIMENTAL; DRUG THERAPY, COMBINATION; EATING; EYE; INSULIN; LIPID PEROXIDES; MALE; PROBUCOL; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; TIME FACTORS; TRIGLYCERIDES;

EID: 18844378615     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.03.004     Document Type: Article

References (36)

1. D. Armstrong, and F. Al-Awadi Lipid peroxidation and retinopathy in streptozotocin-induced diabetes Free Radic. Biol. Med. 11 1991 433 436
2. M.W. Baumastark, R. Aristegui, T. Zoller, I. Frey, A. Berg, and J. Keul Probucol, incorporated into LDL particles in vivo, inhibits generation of lipid peroxides more effectively than endogenous antioxidants alone Clin. Biochem. 25 1992 395 397
3. J.W. Baynes Role of oxidative stress in development of complications in diabetes Diabetes 40 1991 405 412
4. M. Brownlee Glycation products and the pathogenesis of diabetic complications Diabetes Care 15 1992 1835 1843
5. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycosylation endproducts in tissue and the biochemical basis of diabetic complications N. Engl. J. Med. 318 1988 1315 1321
6. H.C. Chen, M.S. Tan, J.Y. Guh, H.H. Tsai, and Y.L. Lai Native and oxidized low-density lipoproteins enhance superoxide production from diabetic rat glomeruli Kidney Blood Press. Res. 23 2000 133 137
7. J.H. Dominguez, N. Tang, W. Xu, E.P. Evan, A.N. Siakotos, R. Agarwal, J. Walsh, M. Deeg, J.H. Pratt, K.L. March, V.M. Weiss, M.F. Baynes, and J.W. Peterson Studies of renal injury III: lipid-induced nephropathy in type II diabetes Kidney Int. 57 2000 92 104
8. M.J. Garcia, P.M. McNamara, T. Gordon, and W.B. Kannel Morbidity and mortality in diabetics in the Framingham population Diabetes 23 1974 105 111
9. S. Gorogawa, Y. Kajimoto, Y. Umayahara, H. Kaneto, H. Watada, A. Kuroda, D. Kawamori, T. Yasuda, M. Matsuhisa, Y. Yamasaki, and M. Hori Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes Diabetes Res. Clin. Pract. 57 2002 1 10
10. A. Gottsater, M. Ahmed, P. Fernlund, and G. Sundkvist Autonomic europathy in type 2 diabetic patients is associated with hyperinsulinanemia and hypertriglyceridaemia Diabet. Med. 16 1999 49 54
11. B. Gurler, H. Vural, N. Yilmaz, A. Satici, and N. Aksoy The role of oxidative stress in diabetic retinopathy Eye 14 Pt. 5 2000 730 735
12. T. Hirano, J.C.L. Mamo, H. Takeuchi, S. Nagano, and T. Takahashi Correlation of insulin deficiency and hypertriglyceridemia in diabetic rats Diabetes Res. Clin. Pract. 12 1991 173 180
13. J.V. Hund, C.C. Smith, and S.P. Wolff Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose Diabetes 39 1991 1420 1424
14. M. Ito, Y. Kondo, A. Nakatani, K. Hayashi, and A. Naruse Characterization of low dose streptozotocin-induced progressive diabetes in mice Environ. Toxicol. Pharmacol. 9 2001 71 78
15. V. Jakus The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease Bratisl. Lek. L. 101 2000 541 551
16. J.H. Kinoshita, S. Fukushi, P. Kador, and L.O. Merola Aldose reductase in diabetic complications of the eye Metabolism 28 1979 462 469
17. J. Kusunoki, K. Aragane, T. Kitamine, H. Kozono, K. Kano, K. Fujinami, K. Kojima, T. Chiwata, and Y. Sekine Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A: cholesterol acetyltransferase activity Arterioscler. Thromb. Vasc. Biol. 20 2000 171 178
18. M. Lu, S. Amano, K. Miyamoto, R. Garland, K. Keough, W. Qin, and A.P. Adamis Insulin-induced vascular endothelial growth factor expression in retina Investig. Ophthalmol. Vis. Sci. 40 1999 3281 3286
19. Z.-W. Man, M. Zhu, Y. Noma, K. Toide, T. Sato, Y. Asahi, T. Hirashima, S. Mori, K. Kawano, A. Mizuno, T. Sano, and K. Shima Impaired β-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM Diabetes 46 1997 1718 1724
20. M. Matsushita, G. Yoshino, M. Iwai, K. Matsuba, M. Morita, I. Iwatani, M. Yoshida, T. Kazumi, and S. Baba Protective effect of probucol on alloxan diabetes in rats Diabetes Res. Clin. Pract. 7 1989 313 316
21. H. Mochizuki, J. Takido, H. Oda, and H. Yokogoshi Improving effect of dietary taurine on marked hypercholesterolemia induced by a high-cholesterol diet in streptozotocin-induced diabetic rats Biosci. Biotechnol. Biochem. 63 1999 1984 1987
22. A. Mügge, R.P. Brandes, R.H. Böger, A. Dwenger, S. Bodr-Böger, J.C. Frölich, and P.R. Lichtlen Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits J. Cardiovasc. Pharmacol. 24 1994 994 998
23. E.A. Nikkila, and P. Hormila Serum lipid and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations Diabetes 27 1978 1078 1085
24. E.A. Nikkila, and M. Kekki Plasma triglyceride transport kinetics in diabetes mellitus Metabolism 22 1973 1 22
25. S. Parthasarathy, S.G. Young, J.L. Witzum, R.C. Pittman, and D. Steinberg Probucol inhibits oxidative modification of low density lipoprotein J. Clin. Invest. 77 1986 641 644
26. M. Ravid, D. Brosh, D. Ravid-Safran, Z. Levy, and R. Rachmani Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia Arch. Intern. Med. 158 1998 998 1004
27. G.M. Reaven, and M.S. Greenfield Diabetic hypertriglyceridemia. Evidence for three clinical syndromes Diabetes 30 Suppl. 2 1981 66 75
28. J. Regnstrom, D. Walldius, L.A. Carlson, and J. Nilsson Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro Atherosclerosis 82 1990 43 51
29. T. Sakurai, and S. Tsuchiya Superoxide production from nonenzymatically glycation protein FEBS Lett. 236 1988 406 410
30. C.J. Schwartz The probucol experience: a review of the past and a look at the future Am. J. Cardiol. 62 1988 1B 5B
31. Y.T. Sia, T.G. Perker, P. Liu, J.N. Tsoporis, A. Adam, and J.L. Rouleau Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression J. Am. Coll. Cardiol. 39 2002 148 156
32. E.N. Su, V.A. Alder, D.Y. Yu, P.K. Yu, S.J. Cringle, and K. Yogesan Continued recovery to normoglycemia in a long-term study of streptozotocin- induced diabetes in rats Graefe Arch. Clin. Exp. Ophthalmol. 238 2000 163 173
33. K. Tsutsumi, Y. Inoue, and C. Yoshida Acceleration of Development of diabetic cataract by hyperlipidemia and low high-density lipoprotein in rats Biol. Pharm. Bull. 22 1999 37 41
34. I.C. West Radicals and oxidative stress in diabetes Diabet. Med. 17 2000 171 180
35. K. Yagi A simple fluorometric assay for lipoperoxide in blood plasma Biochem. Med. 15 1976 212 216
36. A. Yamamoto, Y. Matsuzawa, S. Yokoyama, T. Funahashi, T. Yamamura, and B. Kishino Effects of probucol on xanthomata regression in familiar hypercholesterolemia Am. J. Cardiol. 57 1986 29H 35H